References
- 1. Griggs RC, Bushby K. Continued need for caution in the diagnosis of Duchenne muscular dystrophy. Neurology. 2005; 64(10): 1498-1499.
- 2. Barnea E, Zuk D, Simantov R, Nudel U, Yaffe D. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron. 1990; 5(6): 881-888.
- 3. Boyce FM, Beggs AH, Feener C, Kunkel LM. Dys-trophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA. 1991; 88(4): 1276-1280.
- 4. Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard AE, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet. 1992; 1(7): 505-510.
- 5. Hugnot JP, Gilgenkrantz H, Vincent N, Chafey P, Morris GE, Monaco AP, et al. Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in non muscle tissues. Proc Natl Acad Sci USA. 1992; 89(16): 7506-7510.
- 6. Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O, et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci USA. 1992; 89(12): 5346-5350.
- 7. Rapaport D, Passos-Bueno MR, Takata RI, Campiotto S, Eggers S, Vainzof M, et al. A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation. Neuromusc Disord. 1992; 2(2): 117-120.
- 8. Byers TJ, Lidov HGW, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993; 4(1): 77-81.
- 9. Pereira CC, Kiyomoto BH, Cardoso R, Oliveira AS. Duchenne muscular dystrophy, α-dystroglycan immuno-expression in skeletal muscle and cognitive performance. Arq Neuropsiquiatr. 2005; 63(4): 984-989.
- 10. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, et al. N. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy Neurology. 2000; 55(4): 559-564.
- 11. Billard C, Gillet P, Signoret JL, Uicaut E, Bertrand P, Fardeau M, et al. Cognitive functions in Duchenne muscular dystrophy: A reappraisal and comparison with spinal muscular atrophy. Neuromusc Disord. 1992; 2(5-6): 371-378.
- 12. Moizard M, Billard C, Toutain A, Berret F, Marmin N, Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998; 80(1): 32-41.
- 13. Cotton S, Voudouris NJ, Greenwood KM. Intel-ligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001; 43(7): 497-501.
- 14. Schneider SC, Tan G. Attention-deficit hyperactivity disorder. In pursuit of diagnostic accuracy. Postgrad Med. 1997; 101(4): 231-232.
- 15. Bardoni A, Sironi M, Felisari G, Comi GP, Bresolin N. Absence of brain Dp140 isoform and cognitive impairment in Becker muscular dystrophy. Lancet 1999; 353(9156): 897-898.
- 16. Young HK, Barton BA, Waisbren S, Dale LP, Ryan MM, Webster RI, et al. Cognitive and psychological profile of males with Becker muscular dystrophy. J Child Neurol. 2008; 23(2): 155-162.
- 17. D’Angelo MG, Bresolin N. Cognitive impairment in neuromuscular disorders. Muscle Nerve. 2006; 34(1): 16-33.
- 18. Bardoni A, Felisari G, Sironi M, Comi G, Lai M, Robotti M, et al. Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromusc Dis. 2000; 10(3): 194-199.
- 19. Lidov HGW, Selg S, Kunkel LM. Dp140: a novel 140 KDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995; 4(3): 329-335.
- 20. Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS ONE 2010; 5(1): 1-9.
- 21. Bhat S, Schmidt K, Ladd S, Kim K, Schwartz C, Simensen RJ, et al. Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenet Genome Res. 2006; 112(1-2): 170-175.
- 22. Moizard M, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, et al. Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 2000; 8(7): 552-556.
- 23. Anderson JL, Head SI, Rae C, Morely JW. Brain function in Duchenne muscular dystrophy. Brain. 2002; 125(Pt 1): 4-13.
- 24. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, et al. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011; 18(1): 90-95.
- 25. D’Angelo MG, Lorusso, Civati F, Comi GP, Magri F, Del Bo R, et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011; 45(5): 292-299.